Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TFEB | P19484 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6291897 | 1.00 | TDP1 (0.65) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244254 | 0.91 | TDP1 (0.61) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244199 | 0.90 | TDP1 (0.57) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244481 | 0.90 | TDP1 (0.57) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244200 | 0.90 | TDP1 (0.57) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244380 | 0.89 | TDP1 (0.56) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244381 | 0.89 | TDP1 (0.56) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| Octinoxate SCHEMBL19717857 | 0.88 | TDP1 (0.74) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244289 | 0.88 | TDP1 (0.55) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL19244402 | 0.88 | TDP1 (0.55) | TDP1ALDH1A1KDM4EHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676428-A1 | LIQUID UV FILTER COMPOSITION CONTAINING DIOLS | Symrise AG (DE) | 2026-01-14 | — | — | EP | claimed |
| EP-4676433-A1 | LIQUID UV FILTER CONCENTRATE | Symrise AG (DE) | 2026-01-14 | — | — | EP | claimed |
| EP-4157213-A1 | SUNSCREEN WITH A COMBINATION OF CARNAUBA WAX AND HYDROGENATED RAPESEED OIL | Beiersdorf AG (DE) | 2023-04-05 | — | — | EP | claimed |
| EP-4103148-A1 | POLYACRYLATE-FREE COSMETIC PREPARATION | Beiersdorf AG (DE) | 2022-12-21 | — | — | EP | claimed |
| WO-2021064116-A1 | COMPOSITIONS WITH POLYMERIC OR OLIGOMERIC HYDROXY PHENYL TRIAZINE UV FILTER | BASF SE (DE) | 2021-04-08 | — | — | WO | claimed |
| CN-112048383-A | Rose essence and its preparing process | 浙江绿晶生物科技股份有限公司 | 2020-12-08 | — | — | CN | claimed |
| EP-3651725-A1 | SUNSCREEN WITH PROTECTION AGAINST TEXTILE SPOTTING DUE TO 2,4-BIS-{[4-(2-ETHYL-HEXYL-OXY)-2-HYDROXY]-PHENYL}-6-(4-METHOXYPHENYL)-1,3,5-TRIAZINE | Beiersdorf AG (DE) | 2020-05-20 | — | — | EP | claimed |
| EP-3651723-A1 | SUNSCREEN WITH A PROTECTION AGAINST TEXTILE SPOTTING DUE TO 4-(TERT-BUTYL)-4´-METHOXYDIBENZOYLMETHANE | Beiersdorf AG (DE) | 2020-05-20 | — | — | EP | claimed |
| EP-2775997-B1 | COSMETIC AND DERMATOLOGICAL PHOTOPROTECTIVE PREPARATION WITH IMPROVED WATER RESISTANCE | BEIERSDORF AG (DE) | 2019-08-07 | — | — | EP | claimed |
| EP-1755543-B1 | ANTI-COLOUR FADING COMPOSITION | SENSIENT COSMETIC TECHNOLOGIES (FR) | 2015-10-28 | — | — | EP | claimed |
| US-20090057627-A1 | Method of quenching electronic excitation of chromophore-containing organic molecules photoactive compositions | HALLSTAR INNOVATIONS CORP. (US) | 2009-03-05 | — | — | US | claimed |
| US-20080199526-A1 | Composition With Tight Capsules Containing a Sunscreen Agent | DSM IP ASSETS B.V. (NL) | 2008-08-21 | — | — | US | claimed |
| EP-1899015-A1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSMIP Assets B.V. (NL) | 2008-03-19 | — | — | EP | claimed |
| EP-1888015-A1 | SKIN LIGHTENING COMPOSITION COMPRISING A CONJUGATED LINOLEIC ACID AND NIACINAMIDE | Unilever Plc (GB) | 2008-02-20 | — | — | EP | claimed |
| WO-2007000316-A1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSM IP ASSETS B.V. (NL) | 2007-01-04 | — | — | WO | claimed |
| WO-2006117055-A1 | SKIN LIGHTENING COMPOSITION COMPRISING A CONJUGATED LINOLEIC ACID AND NIACINAMIDE | UNILEVER PLC (GB) | 2006-11-09 | — | — | WO | claimed |
| EP-0910335-B1 | INSECT REPELLENT SUNSCREEN | JOHNSON & SON INC S C (US) | 2002-10-16 | — | — | EP | claimed |
| EP-0910335-A1 | INSECT REPELLENT SUNSCREEN | S.C. JOHNSON & SON, INC. (US) | 1999-04-28 | — | — | EP | claimed |
| US-5716602-A | AQUEOUS EMULSIONS OF ORGANIC SUNSCREEN AGENTS WHICH ABSORB ULTRAVIOLET RADIATION, INSECT REPELLING COMPOUNDS, EMULSIFIER AND NEOPENTANOATE | S. C. JOHNSON & SONS, INC. (US) | 1998-02-10 | — | — | US | claimed |
| WO-1997049380-A1 | INSECT REPELLENT SUNSCREEN | S.C. JOHNSON & SON, INC. (US) | 1997-12-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080199526-A1 | Composition With Tight Capsules Containing a Sunscreen Agent | SUN2, DSG1, DSC1 | TDP1 3860/4885ALDH1A1 258/4885KDM4E 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.